Dr. Carl Weiner, MD, OB, MFM, MBA

Dr. Weiner spent many years as a practicing OB and is currently the founder and chief medical officer of NALA diagnostics, a diagnostics company that creates tools to predict the likelihood of preterm birth and preeclampsia in the first/second trimester

Maternal Plasma RNA in First Trimester Nullipara for the Prediction of Spontaneous Preterm Birth ≤ 32 Weeks: Validation Study, 2023

Evaluation of a Maternal Plasma RNA Panel Predicting Spontaneous Preterm Birth and Its Expansion to the Prediction of Preeclampsia, 2022

Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women, 2017

Find more of Dr. Weiner’s published academic work here